Tango Therapeutics TNGX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.18M+29.6% | $1.68M+53.1% | $1.1M-11.5% | $1.24M-23.2% | $1.61M-11.0% | ||
| $0— | $0-100% | $53.81M+1,592% | $3.18M-41.0% | $5.39M+31.0% | ||
| $33.53M+4.5% | $32.1M+4.2% | $30.82M-6.1% | $32.81M-10.0% | $36.44M+7.4% | ||
| $48.77M+16.5% | $41.86M+5.3% | $39.74M-10.0% | $44.15M-7.9% | $47.92M+6.4% | ||
| $48.77M+16.5% | $41.86M+5.3% | $39.74M-10.0% | $44.15M-7.9% | $47.92M+6.4% | ||
| $3.26M+6.4% | $3.06M+69.8% | $1.8M-16.1% | $2.15M-20.1% | $2.69M-18.3% | ||
| -$45.51M-17.5% | -$38.75M-344% | $15.88M+141% | -$38.85M+2.6% | -$39.88M-5.9% | ||
| -$0.32-6.7% | -$0.30-314% | $0.14+140% | -$0.35+2.8% | -$0.36-5.9% | ||
| 143.6M+23.6% | 116.2M+4.7% | 111M+0.4% | 110.5M+0.2% | 110.3M+1.0% | ||
| -$45.85M-18.6% | -$38.65M-343% | $15.91M+141% | -$38.95M+2.7% | -$40.02M-5.1% | ||
| $2.18M+29.6% | $1.68M+53.1% | $1.1M-11.5% | $1.24M-23.2% | $1.61M-11.0% | ||
| $79.85M-63.6% | $219.38M+8,533% | $2.54M+337% | $581K+28,950% | $2K-99.8% | ||
| $9.64M+107% | -$135.72M-386% | $47.48M+183% | $16.78M-45.2% | $30.6M-41.2% | ||
| -$44.36M-49.3% | -$29.72M+4.0% | -$30.95M+15.2% | -$36.52M+12.4% | -$41.7M-13.8% | ||
| $1.08M-21.8% | $1.38M+95.7% | $705K-22.5% | $910K-15.3% | $1.07M-27.2% | ||
| $537K+5,867% | $9K0.0% | $9K0.0% | $9K0.0% | $9K— | ||
| -$48.31M-16.7% | -$41.39M-383% | $14.63M+136% | -$40.34M+3.7% | -$41.91M-4.0% | ||
| -$48.77M-16.5% | -$41.86M-397% | $14.07M+134% | -$40.97M+3.7% | -$42.53M-4.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Tango Therapeutics's income statement data come from?
- Every line is extracted from Tango Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.